Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province

Objectives To explore the immune-related genetic susceptibility of human leukocyte antigen (HLA) alleles and their correlation with panel reactive antibody (PRA) generation during end-stage renal disease (ESRD) progression. Materials and methods Data of the expression patterns of HLA-A, -B, and -DR alleles and PRAs of 347 ESRD patients awaiting renal transplantation in Hunan Province from 2015 to 2019 were retrospectively studied. The polymerase chain reaction with sequence-specific primers was used for HLA genotyping and the enzyme-linked immunosorbent assay for PRA detection. SPSS 21.0 software was used for all allele frequency and statistical analyses. Results Thirteen HLA-A, 25 HLA-B, and 13 HLA-DR alleles were expressed. The allele frequencies of HLA-A2, -B48, -B52, and -B55 were significantly higher in the case group than in the control group (p < 0.05), whereas that of HLA-B60 was significantly higher in the control group (p < 0.05). The frequency of HLA alleles in the PRA-positive group was significantly higher in females than in males (p < 0.05). The allele frequencies of HLA-A2, -B38, and -B46 were significantly higher in the PRA-positive group than in the PRA-negative one (p < 0.05), whereas that of HLA-60 was significantly higher in the PRA-negative group (p < 0.05). Conclusion HLA-A2, -B48, -B52, and -B55 may be the ESRD susceptibility alleles in Han Chinese patients in Hunan Province, whereas HLA-B60 may be the protective allele. Patients carrying HLA-A2, -B38, and -B46 are more likely to develop PRA positivity, whereas the opposite is true for those with HLA-B60.